Alligo AB Series B
Alligo AB (publ) engages in the provision of workwear, personal protective equipment, tools, and consumables in Finland, Sweden, and Norway. The company offers personal protective equipment and clothing, such as Workwear, footwear, gloves, protective equipment, corporate branded clothing, and accessories; and machinery, hand tools, electric tools, and measuring tools, as well as cutting, grinding… Read more
Alligo AB Series B (ALLIGO-B) - Total Liabilities
Latest total liabilities as of September 2025: Skr5.95 Billion SEK
Based on the latest financial reports, Alligo AB Series B (ALLIGO-B) has total liabilities worth Skr5.95 Billion SEK as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Alligo AB Series B - Total Liabilities Trend (2013–2024)
This chart illustrates how Alligo AB Series B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Alligo AB Series B Competitors by Total Liabilities
The table below lists competitors of Alligo AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gempharmatech Co. Ltd. A
SHG:688046
|
China | CN¥630.58 Million |
|
Alivus Life Sciences Limited
NSE:ALIVUS
|
India | ₹6.23 Billion |
|
Amorepacific Group
KO:002795
|
Korea | ₩1.39 Trillion |
|
Betagro Public Company Limited
F:J74
|
Germany | €37.92 Billion |
|
Hangzhou Huaxing Chuangye Communication Technology Co Ltd
SHE:300025
|
China | CN¥357.87 Million |
|
Regional Container Lines Public Company Limited
BK:RCL
|
Thailand | ฿22.80 Billion |
|
Wuhan Huakang Century Medical Co. Ltd.
SHE:301235
|
China | CN¥2.01 Billion |
|
RMK Energy PT Tbk
JK:RMKE
|
Indonesia | Rp811.45 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Alligo AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.09 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alligo AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alligo AB Series B (2013–2024)
The table below shows the annual total liabilities of Alligo AB Series B from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr5.92 Billion | +14.94% |
| 2023-12-31 | Skr5.15 Billion | +3.98% |
| 2022-12-31 | Skr4.95 Billion | -5.35% |
| 2021-12-31 | Skr5.23 Billion | +9.87% |
| 2020-12-31 | Skr4.76 Billion | +56.00% |
| 2019-12-31 | Skr3.05 Billion | +91.11% |
| 2018-12-31 | Skr1.60 Billion | +2.11% |
| 2017-12-31 | Skr1.56 Billion | +1.30% |
| 2016-12-31 | Skr1.54 Billion | -12.02% |
| 2015-12-31 | Skr1.75 Billion | +0.46% |
| 2014-12-31 | Skr1.75 Billion | -3.80% |
| 2013-12-31 | Skr1.82 Billion | -- |